Hyunjin Son Selected Research

Prothionamide (Protionamide)

10/2022

Temporal trends of pharmacologic treatments for tuberculosis and multidrug resistant tuberculosis following dissemination of treatment guidelines in South Korea.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hyunjin Son Research Topics

Disease

2	COVID-19 01/2021 - 06/2020
2	Hypothermia 01/2007 - 01/2007
1	Ototoxicity 10/2022
1	Dementia (Dementias) 01/2021
1	Diabetes Mellitus 01/2021
1	Tuberculosis (Tuberculoses) 01/2021
1	Neoplasms (Cancer) 02/2012
1	Ischemia 01/2007
1	Solitary Kidney 01/2007

Drug/Important Bio-Agent (IBA)

2	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2021 - 06/2020
2	IceIBA 01/2007 - 01/2007
1	Prothionamide (Protionamide)IBA 10/2022
1	Pyrazinamide FDA LinkGeneric 10/2022
1	Streptomycin (Streptomycin Sulfate)FDA Link 10/2022
1	Lopinavir FDA Link 01/2021
1	Pharmaceutical PreparationsIBA 01/2021
1	Ritonavir (Norvir)FDA Link 01/2021
1	Hematoxylin (Haematoxylon)IBA 02/2012
1	Eosine Yellowish-(YS) (Eosin)IBA 02/2012

Therapy/Procedure

1	Long-Term Care 06/2020